tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
EDIT is currently covered by 12 analysts with an average price target of $4.61. This is a potential upside of $1.05 (29.49%) from yesterday's end of day stock price of $3.56.
Editas Medicine's activity chart (see below) currently has 153 price targets and 127 ratings on display. The stock rating distribution of EDIT is 62.5% BUY, 33.33% HOLD and 4.17% SELL.
Analysts average stock forecasts to be materialized ratio is 50.21% with an average time for these price targets to be met of 145.42 days.
Highest price target for EDIT is $6, Lowest price target is $1, average price target is $3.63.
Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 02-Sep-2025. First documented stock forecast 28-Feb-2016.
Currently out of the existing stock ratings of EDIT, 15 are a BUY (62.5%), 8 are a HOLD (33.33%), 1 are a SELL (4.17%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$4
$0.28 (7.53%)
$3
1 months 11 days ago
(02-Sep-2025)
4/9 (44.44%)
$1.5 (60.00%)
51
Buy
$6
$2.28 (61.29%)
$4
2 months 1 days ago
(12-Aug-2025)
2/7 (28.57%)
$2.92 (94.81%)
87
Buy
$4
$0.28 (7.53%)
$5
5 months 1 days ago
(12-May-2025)
3/6 (50%)
$2.5 (166.67%)
54
Sell
$9
9 months 28 days ago
(15-Dec-2024)
2/2 (100%)
$0.14 (1.58%)
9
$3
$-0.72 (-19.35%)
$5
10 months 1 days ago
(12-Dec-2024)
8/12 (66.67%)
$1.56 (108.33%)
200
What is EDIT (Editas Medicine) average time for price targets to be met?
Which analyst has the current highest performing score on EDIT (Editas Medicine) with a proven track record?
Which analyst has the most public recommendations on EDIT (Editas Medicine)?
Which analyst is the currently most bullish on EDIT (Editas Medicine)?
Which analyst is the currently most reserved on EDIT (Editas Medicine)?
